• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大心理社会成瘾项目中阿片类药物使用障碍的治疗:政策、态度和实践的全国性调查。

Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice.

机构信息

Department of Psychology, 192287University of Calgary, Calgary, Alberta.

Addictions and Mental Health Ontario, Toronto, Ontario.

出版信息

Can J Psychiatry. 2022 Aug;67(8):638-647. doi: 10.1177/07067437221082858. Epub 2022 Mar 8.

DOI:10.1177/07067437221082858
PMID:35257596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9301153/
Abstract

OBJECTIVE

To describe current approaches in treatment of opioid use disorder (OUD) within Canadian psychosocial outpatient, day, and residential addiction treatment programs, with an emphasis on the use of opioid agonist therapy (OAT).

METHOD

An online census survey was conducted in English and French of Canadian psychosocial addiction treatment programs ( = 214).

RESULTS

Programs estimated that 25% of their clients have OUD. A slight majority of programs provide some type of specialized services to clients with OUD (58%), most frequently providing or facilitating access to OAT but also specialized counselling, case management, education, and harm reduction services.Most programs reported that they admitted clients on OAT (88%) and only a minority expected or encouraged clients to taper (14%) or discontinue (6%). Programs focusing on client abstinence as the treatment goal were more likely to expect or encourage tapering or discontinuation than programs that focus on helping clients achieve personal consumption goals. Of programs that did not currently facilitate OAT, 44% indicated that they would provide OAT, but lacked the necessary accreditation, physician support, or other resources. No philosophical objections to OAT were noted.OAT initiation was provided by 30% of programs, 23% referred to another service within their organization, and 29% referred to a service outside their organization. The remaining 18% did not facilitate OAT initiation at all, ranging from 0% in Quebec to 23% in the Prairies. Overdose response kits were provided by 86% of programs. The majority not providing kits indicated willingness if policy support and resources were provided (67%).

CONCLUSIONS

Overall, the results demonstrate that psychosocial programs provide some specialized services for OUD but desire further support specifically to provide OAT, including training, knowledge, and the expertise of individuals qualified to prescribe and dispense OAT. Many psychosocial treatment programs expressed a need for staff and resources for this purpose.

摘要

目的

描述加拿大心理社会门诊、日间和住院成瘾治疗项目中治疗阿片类药物使用障碍(OUD)的当前方法,重点介绍阿片类激动剂治疗(OAT)的使用。

方法

用英语和法语对加拿大心理社会成瘾治疗项目进行了在线普查( = 214)。

结果

项目组估计,25%的患者患有 OUD。大多数项目为 OUD 患者提供某种类型的专门服务(58%),最常提供或协助获得 OAT,但也提供专门的咨询、病例管理、教育和减少伤害服务。大多数项目报告说,他们收治了正在接受 OAT 的患者(88%),只有少数项目期望或鼓励患者减少(14%)或停止(6%)。以客户戒断为治疗目标的项目更有可能期望或鼓励减少或停止,而不是以帮助客户实现个人消费目标为重点的项目。在目前不提供 OAT 的项目中,44%表示他们将提供 OAT,但缺乏必要的认证、医生支持或其他资源。没有注意到对 OAT 的任何哲学反对。30%的项目提供 OAT 启动,23%的项目将患者转介到组织内的另一个服务,29%的项目将患者转介到组织外的服务。其余 18%的项目根本不提供 OAT 启动服务,魁北克省为 0%,草原地区为 23%。86%的项目提供了过量反应包。大多数未提供试剂盒的项目表示,如果提供政策支持和资源,他们愿意提供(67%)。

结论

总的来说,结果表明,心理社会项目为 OUD 提供了一些专门的服务,但特别需要进一步的支持,以提供 OAT,包括培训、知识和有资格开处和分发 OAT 的个人的专业知识。许多心理社会治疗项目表示需要为此目的提供人员和资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c3/9301153/e2ff98a87acf/10.1177_07067437221082858-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c3/9301153/e2ff98a87acf/10.1177_07067437221082858-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c3/9301153/e2ff98a87acf/10.1177_07067437221082858-fig1.jpg

相似文献

1
Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice.加拿大心理社会成瘾项目中阿片类药物使用障碍的治疗:政策、态度和实践的全国性调查。
Can J Psychiatry. 2022 Aug;67(8):638-647. doi: 10.1177/07067437221082858. Epub 2022 Mar 8.
2
Comparing Canadian and United States opioid agonist therapy policies.比较加拿大和美国的阿片类激动剂治疗政策。
Int J Drug Policy. 2019 Dec;74:257-265. doi: 10.1016/j.drugpo.2019.01.020. Epub 2019 Feb 11.
3
A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.少数民族人群阿片类激动剂治疗障碍的定性分析。
J Subst Abuse Treat. 2023 Jan;144:108918. doi: 10.1016/j.jsat.2022.108918. Epub 2022 Oct 26.
4
Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan.萨斯喀彻温省家庭医生开具阿片类激动剂治疗药物处方的障碍和促进因素。
Can Fam Physician. 2024 Apr;70(4):e52-e60. doi: 10.46747/cfp.7004e52.
5
Opioid agonist treatment take-home doses ('carries'): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?阿片类激动剂治疗带药回家剂量(“carries”):加拿大和美国的现行指南是否导致高危人群的治疗覆盖率较低?
Harm Reduct J. 2022 Aug 10;19(1):89. doi: 10.1186/s12954-022-00671-z.
6
Malmö Treatment Referral and Intervention Study (MATRIS)-36-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment-The role of stimulant use at baseline.马尔默治疗转诊和干预研究(MATRIS)- 对从针具交换转介到阿片类激动剂治疗的患者的保留率和物质使用情况进行 36 个月随访 - 基线时兴奋剂使用的作用。
J Subst Use Addict Treat. 2023 Aug;151:209036. doi: 10.1016/j.josat.2023.209036. Epub 2023 Apr 11.
7
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.监禁人员中与阿片类药物相关的治疗、干预措施和结果:系统评价。
PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec.
8
Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.评估心理社会干预辅助阿片类激动剂治疗药物使用障碍的比较效果:系统评价和网络荟萃分析。
PLoS One. 2020 Dec 28;15(12):e0244401. doi: 10.1371/journal.pone.0244401. eCollection 2020.
9
Optimising treatment in opioid dependency in primary care: results from a national key stakeholder and expert focus group in Ireland.优化初级保健中阿片类药物依赖的治疗:爱尔兰全国主要利益相关者和专家焦点小组的结果。
BMC Fam Pract. 2018 Jun 30;19(1):103. doi: 10.1186/s12875-018-0792-8.
10
An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions.九个高收入司法管辖区中初级保健中阿片类药物使用障碍治疗的国际比较政策分析。
Health Policy. 2024 Mar;141:104993. doi: 10.1016/j.healthpol.2024.104993. Epub 2024 Jan 12.

引用本文的文献

1
An environmental scan of residential treatment service provision in Ontario.安大略省住宅治疗服务提供情况的环境扫描。
Subst Abuse Treat Prev Policy. 2023 Dec 12;18(1):73. doi: 10.1186/s13011-023-00586-3.
2
Linkage facilitation services for opioid use disorder: Taxonomy of facilitation practitioners, goals, and activities.阿片类药物使用障碍的联系促进服务:促进者的分类、目标和活动。
J Subst Use Addict Treat. 2024 Feb;157:209217. doi: 10.1016/j.josat.2023.209217. Epub 2023 Nov 20.

本文引用的文献

1
Forty-eight years of research on psychosocial interventions in the treatment of opioid use disorder: A scoping review.《阿片类药物使用障碍治疗中的心理社会干预 48 年研究:范围综述》。
Drug Alcohol Depend. 2021 Jan 1;218:108434. doi: 10.1016/j.drugalcdep.2020.108434. Epub 2020 Nov 23.
2
Psychosocial interventions for people with both severe mental illness and substance misuse.针对患有严重精神疾病和药物滥用问题者的社会心理干预措施。
Cochrane Database Syst Rev. 2019 Dec 12;12(12):CD001088. doi: 10.1002/14651858.CD001088.pub4.
3
Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
减少同时存在酒精问题和非法药物使用问题者酒精摄入量的心理社会干预措施。
Cochrane Database Syst Rev. 2018 Dec 5;12(12):CD009269. doi: 10.1002/14651858.CD009269.pub4.
4
The opioid crisis in Canada: a national perspective.加拿大的阿片类药物危机:国家视角。
Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):224-233. doi: 10.24095/hpcdp.38.6.02.
5
Management of opioid use disorders: a national clinical practice guideline.阿片类物质使用障碍的管理:一项国家临床实践指南。
CMAJ. 2018 Mar 5;190(9):E247-E257. doi: 10.1503/cmaj.170958.
6
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
7
A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction.关于心理社会干预联合药物治疗阿片类药物成瘾的系统评价
J Addict Med. 2016 Mar-Apr;10(2):93-103. doi: 10.1097/ADM.0000000000000193.
8
Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society.美沙酮安全性:美国疼痛学会、药物依赖问题学会与心律学会合作制定的临床实践指南
J Pain. 2014 Apr;15(4):321-37. doi: 10.1016/j.jpain.2014.01.494.
9
Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence.心理社会干预联合激动剂维持治疗与单纯激动剂维持治疗用于阿片类物质依赖的治疗
Cochrane Database Syst Rev. 2011 Oct 5(10):CD004147. doi: 10.1002/14651858.CD004147.pub4.